Conn. Biotech Hits Ch. 11 With $2.7M Debt After Patent Suit
By Aaron Keller · September 5, 2025, 4:30 PM EDT
A Connecticut biotech company has filed a voluntary Chapter 11 petition claiming at least $2.7 million in liabilities, mostly debts to Quinn Emanuel Urquhart & Sullivan LLP and Verrill Dana LLP,...
To view the full article, register now.